Cart
sales@molnova.com
VPC-13566
CAS No. 218464-59-6
VPC-13566( VPC13566 | VPC 13566 )
Catalog No. M27935 CAS No. 218464-59-6
VPC-13566 is a BF3-specific small molecule, which effectively inhibited the androgen receptor transcriptional activity and displaced the BAG1L peptide from the BF3 pocket.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 110 | In Stock |
|
| 5MG | 93 | In Stock |
|
| 10MG | 155 | In Stock |
|
| 25MG | 276 | In Stock |
|
| 50MG | 433 | In Stock |
|
| 100MG | 651 | In Stock |
|
| 200MG | 901 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVPC-13566
-
NoteResearch use only, not for human use.
-
Brief DescriptionVPC-13566 is a BF3-specific small molecule, which effectively inhibited the androgen receptor transcriptional activity and displaced the BAG1L peptide from the BF3 pocket.
-
DescriptionVPC-13566 is a BF3-specific small molecule, which effectively inhibited the androgen receptor transcriptional activity and displaced the BAG1L peptide from the BF3 pocket. VPC-13566 inhibits the growth of various prostate cancer cell lines and reduces the growth of AR-dependent prostate cancer xenograft tumors in mice.
-
In Vitro——
-
In Vivo——
-
SynonymsVPC13566 | VPC 13566
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number218464-59-6
-
Formula Weight258.324
-
Molecular FormulaC18H14N2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (387.12 mM)
-
SMILESCc1cccc2c(c[nH]c12)-c1ccc2ccccc2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Anthony Boitano, et al. Aryl hydrocarbon receptor antagonists and methods of use thereof for treating various diseases. WO2020051207A2
molnova catalog
related products
-
Trenbolone acetate
Trenbolone acetate (RU-1697,17beta-TBOH) is a potent testosterone analog and selective androgen receptor modulator.
-
ARN-509
ARN-509 is a selective and competitive androgen receptor inhibitor with IC50 of 16 nM in a cell-free assay, useful for prostate Y treatment.
-
JNJ-63576253
JNJ-63576253 is a potent and orally active full antagonist of androgen receptor (AR), with IC50s of 37 and 54 nM for F877L mutant AR and wild-type AR in LNCaP cells.?
